About Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 is a rare disease catalogued by Orphanet (ORPHA:177904). It is associated with the SNORD115@, SNRPN, MAGEL2 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 trials.
Search ClinicalTrials.gov for "Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2" or filter by Orphanet code ORPHA:177904 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2. Updated daily.